{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:58:53Z","timestamp":1792292333182,"version":"4.4.0"},"reference-count":155,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","sleep.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Clinics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jsmc.2021.02.012","type":"journal-article","created":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T03:02:18Z","timestamp":1618023738000},"page":"249-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Akathisia and Restless Legs Syndrome"],"prefix":"10.1016","volume":"16","author":[{"given":"Sergi","family":"Ferr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Guitart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Quiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Garc\u00eda-Malo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Garcia-Borreguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Earley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jsmc.2021.02.012_bib1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1073858418791763","article-title":"New insights into the neurobiology of restless legs syndrome","volume":"25","author":"Ferr\u00e9","year":"2019","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jsmc.2021.02.012_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1192\/bjp.143.2.139","article-title":"Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions","volume":"143","author":"Braude","year":"1983","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1192\/bjp.164.2.177","article-title":"Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia","volume":"164","author":"Halstead","year":"1994","journal-title":"Br J Psychiatry"},{"issue":"5","key":"10.1016\/j.jsmc.2021.02.012_bib5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4088\/JCP.08r04210","article-title":"Akathisia: an updated review focusing on second-generation antipsychotics","volume":"70","author":"Kane","year":"2009","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.jsmc.2021.02.012_bib6","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/S1353-8020(13)70028-2","article-title":"Tardive dyskinesia syndromes: current concepts","volume":"20","author":"Aquino","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jsmc.2021.02.012_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jns.2018.02.008","article-title":"The nosology of tardive syndromes","volume":"389","author":"Frei","year":"2018","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jsmc.2021.02.012_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.sleep.2015.11.018","article-title":"Diagnostic accuracy of the standard and alternative periodic leg movement during sleep indices for restless legs syndrome","volume":"22","author":"Ferri","year":"2016","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.jsmc.2021.02.012_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11940-017-0446-5","article-title":"The clinical importance of periodic leg movements in sleep","volume":"19","author":"Figorilli","year":"2017","journal-title":"Curr Treat Options Neurol"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ncl.2012.08.004","article-title":"Restless legs syndrome and periodic leg movements of sleep","volume":"30","author":"Rye","year":"2012","journal-title":"Neurol Clin"},{"issue":"3","key":"10.1016\/j.jsmc.2021.02.012_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/ana.24593","article-title":"Prevalence and determinants of periodic limb movements in the general population","volume":"79","author":"Haba-Rubio","year":"2016","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.jsmc.2021.02.012_bib12","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.5665\/sleep.4006","article-title":"Periodic leg movements during sleep are associated with polymorphisms in BTBD9, TOX3\/BC034767, MEIS1, MAP2K5\/SKOR1, and PTPRD","volume":"37","author":"Moore","year":"2014","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000026658","article-title":"Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality","volume":"41","author":"Saletu","year":"2000","journal-title":"Neuropsychobiology"},{"issue":"6","key":"10.1016\/j.jsmc.2021.02.012_bib14","first-page":"919","article-title":"An evidence-based analysis of the association between periodic leg movements during sleep and arousals in restless legs syndrome","volume":"38","author":"Ferri","year":"2015","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.sleep.2007.11.024","article-title":"Evaluating daytime alertness in individuals with Restless Legs Syndrome (RLS) compared to sleep restricted controls","volume":"10","author":"Gamaldo","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.jsmc.2021.02.012_bib16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3389\/fnins.2017.00722","article-title":"Pivotal role of adenosine neurotransmission in restless legs syndrome","volume":"11","author":"Ferr\u00e9","year":"2018","journal-title":"Front Neurosci"},{"issue":"7","key":"10.1016\/j.jsmc.2021.02.012_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects","volume":"49","author":"Farde","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S003329170003960X","article-title":"The pathophysiology of extrapyramidal side-effects of neuroleptic drugs","volume":"10","author":"Marsden","year":"1980","journal-title":"Psychol Med"},{"key":"10.1016\/j.jsmc.2021.02.012_bib19","series-title":"Pre- and postsynaptic receptors","first-page":"49","article-title":"Receptor-mediated control of dopamine metabolism","author":"Carlsson","year":"1975"},{"key":"10.1016\/j.jsmc.2021.02.012_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1748-1716.1971.tb05213.x","article-title":"Drug-induced changes in the release of 3 H-monoamines from field stimulated rat brain slices","volume":"371","author":"Farnebo","year":"1971","journal-title":"Acta Physiol Scand Suppl"},{"key":"10.1016\/j.jsmc.2021.02.012_bib21","series-title":"Frontiers in catecholamine research","first-page":"643","article-title":"Central dopaminergic neurons: neurophysiological identification and responses to drugs","author":"Aghajanian","year":"1973"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00508803","article-title":"Dopamine\"autoreceptors\": pharmacological characterization by microiontophoretic single cell recording studies","volume":"297","author":"Aghajanian","year":"1977","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neubiorev.2004.05.001","article-title":"The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems","volume":"28","author":"Adell","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jsmc.2021.02.012_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","article-title":"The role of D2-autoreceptors in regulating dopamine neuron activity and transmission","volume":"282","author":"Ford","year":"2014","journal-title":"Neuroscience"},{"issue":"1672","key":"10.1016\/j.jsmc.2021.02.012_bib25","doi-asserted-by":"crossref","first-page":"20140185","DOI":"10.1098\/rstb.2014.0185","article-title":"Somatodendritic dopamine release: recent mechanistic insights","volume":"370","author":"Rice","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.jsmc.2021.02.012_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/FBP.0b013e32833a5c68","article-title":"Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats","volume":"21","author":"Li","year":"2010","journal-title":"Behav Pharmacol"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1073\/pnas.1717194115","article-title":"Differential regulation of striatal motor behavior and related cellular responses by dopamine D2L and D2S isoforms","volume":"115","author":"Radl","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.jsmc.2021.02.012_bib29","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nn.2862","article-title":"Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors","volume":"14","author":"Bello","year":"2011","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(91)91456-B","article-title":"Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA","volume":"564","author":"Bouthenet","year":"1991","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.jsmc.2021.02.012_bib31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0306-4522(94)00527-C","article-title":"Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain","volume":"65","author":"Diaz","year":"1995","journal-title":"Neuroscience"},{"issue":"23","key":"10.1016\/j.jsmc.2021.02.012_bib32","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1523\/JNEUROSCI.20-23-08677.2000","article-title":"Dopamine D3 receptors expressed by all mesencephalic dopamine neurons","volume":"20","author":"Diaz","year":"2000","journal-title":"J\u00a0Neurosci"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0893-133X(98)00066-9","article-title":"Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons","volume":"20","author":"Gurevich","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jsmc.2021.02.012_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.nbd.2014.12.007","article-title":"Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake","volume":"74","author":"Castro-Hern\u00e1ndez","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.jsmc.2021.02.012_bib35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/jnc.13732","article-title":"Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter","volume":"138","author":"McGinnis","year":"2016","journal-title":"J\u00a0Neurochem"},{"issue":"8","key":"10.1016\/j.jsmc.2021.02.012_bib36","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41386-019-0371-2","article-title":"Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens","volume":"44","author":"Manvich","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"2\u20133","key":"10.1016\/j.jsmc.2021.02.012_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0301-0082(80)90018-0","article-title":"From motivation to action: functional interface between the limbic system and the motor system","volume":"14","author":"Mogenson","year":"1980","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jsmc.2021.02.012_bib38","series-title":"Adenosine receptors in neurodegenerative diseases","first-page":"231","article-title":"Adenosine control of striatal Function. Implications for the treatment of apathy in basal ganglia disorders","author":"Ferr\u00e9","year":"2017"},{"key":"10.1016\/j.jsmc.2021.02.012_bib39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fphar.2018.00243","article-title":"Essential control of the function of the striatopallidal neuron by pre-coupled complexes of adenosine a2a-dopamine d2 receptor heterotetramers and adenylyl cyclase","volume":"9","author":"Ferr\u00e9","year":"2018","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","article-title":"A\u00a0psychomotor stimulant theory of addiction","volume":"94","author":"Wise","year":"1987","journal-title":"Psychol Rev"},{"issue":"3","key":"10.1016\/j.jsmc.2021.02.012_bib41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0006-8993(75)90233-4","article-title":"Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum","volume":"94","author":"Kelly","year":"1975","journal-title":"Brain Res"},{"key":"10.1016\/j.jsmc.2021.02.012_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3758\/BF03332184","article-title":"Microinjections of d-amphetamine into the nucleus accumbens and caudate-putamen differentially affect stereotypy and locomotion in the rat","volume":"12","author":"Staton","year":"1984","journal-title":"Physiol Psycol"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0091-3057(87)90485-0","article-title":"Effects of systemic and intracranial amphetamine injections on behavior in the open field: a detailed analysis","volume":"27","author":"Carr","year":"1987","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0166-4328(89)80005-1","article-title":"Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior","volume":"35","author":"Kelley","year":"1989","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib45","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF00589908","article-title":"Interaction between accumbens D1 and D2 receptors regulating rat locomotor activity","volume":"99","author":"Plaznik","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jsmc.2021.02.012_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1523\/JNEUROSCI.10-01-00303.1990","article-title":"Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat","volume":"10","author":"Delfs","year":"1990","journal-title":"J\u00a0Neurosci"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib47","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0306-4522(02)00247-6","article-title":"Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1\/D2 agonists","volume":"113","author":"Ikemoto","year":"2002","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(76)90352-6","article-title":"Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats","volume":"40","author":"Kelly","year":"1976","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0306-4522(90)90221-O","article-title":"The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum","volume":"39","author":"Delfs","year":"1990","journal-title":"Neuroscience"},{"issue":"13","key":"10.1016\/j.jsmc.2021.02.012_bib50","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/mds.22599","article-title":"Substance abuse and movement disorders","volume":"25","author":"Brust","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.jsmc.2021.02.012_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fneur.2015.00075","article-title":"Psychostimulants and movement disorders","volume":"6","author":"Asser","year":"2015","journal-title":"Front Neurol"},{"key":"10.1016\/j.jsmc.2021.02.012_bib52","series-title":"The rat nervous system","first-page":"445","article-title":"Basal ganglia","author":"Gerfen","year":"2004"},{"issue":"2\u20133","key":"10.1016\/j.jsmc.2021.02.012_bib53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(86)90588-1","article-title":"Obligatory D-1\/D-2 receptor interaction in the generation of dopamine agonist related behaviors","volume":"131","author":"Braun","year":"1986","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(87)90144-0","article-title":"Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats","volume":"133","author":"Arnt","year":"1987","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib55","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-8993(89)90831-7","article-title":"Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats","volume":"487","author":"Dreher","year":"1989","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib56","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0006-8993(89)91368-1","article-title":"Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats","volume":"504","author":"Bordi","year":"1989","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.jsmc.2021.02.012_bib57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.2042-7158.1988.tb05228.x","article-title":"Dopamine-mediated behaviours produced in naive mice by bromocriptine plus SKF 38393","volume":"40","author":"Jackson","year":"1988","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0306-4522(87)90208-9","article-title":"Behavioural role of dopamine D1 receptors in the reserpine-treated mouse","volume":"22","author":"Starr","year":"1987","journal-title":"Neuroscience"},{"issue":"1\u20133","key":"10.1016\/j.jsmc.2021.02.012_bib59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-2999(94)90099-X","article-title":"Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors","volume":"255","author":"Ferr\u00e9","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib60","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001756-199412300-00020","article-title":"Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors","volume":"6","author":"Ferr\u00e9","year":"1994","journal-title":"Neuroreport"},{"issue":"15","key":"10.1016\/j.jsmc.2021.02.012_bib61","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1073\/pnas.150241097","article-title":"Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes","volume":"97","author":"Gin\u00e9s","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib62","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.2007.05196.x","article-title":"An update on the mechanisms of the psychostimulant effects of caffeine","volume":"105","author":"Ferr\u00e9","year":"2008","journal-title":"J\u00a0Neurochem"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib63","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/s41467-018-03522-3","article-title":"Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase","volume":"9","author":"Navarro","year":"2018","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.jsmc.2021.02.012_bib64","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00213-016-4212-2","article-title":"Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders","volume":"233","author":"Ferr\u00e9","year":"2016","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib65","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s12035-018-1120-y","article-title":"Adenosine A1-Dopamine D1 receptor heteromers control the excitability of the spinal motoneuron","volume":"56","author":"Rivera-Oliver","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"17","key":"10.1016\/j.jsmc.2021.02.012_bib66","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1523\/JNEUROSCI.20-17-06666.2000","article-title":"Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials","volume":"20","author":"LaHoste","year":"2000","journal-title":"J\u00a0Neurosci"},{"issue":"12","key":"10.1016\/j.jsmc.2021.02.012_bib67","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1523\/JNEUROSCI.23-12-05079.2003","article-title":"Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits","volume":"23","author":"Hopf","year":"2003","journal-title":"J\u00a0Neurosci"},{"issue":"20","key":"10.1016\/j.jsmc.2021.02.012_bib68","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1523\/JNEUROSCI.16-20-06579.1996","article-title":"Coordinated expression of dopamine receptors in neostriatal medium spiny neurons","volume":"16","author":"Surmeier","year":"1996","journal-title":"J\u00a0Neurosci"},{"issue":"2\u20133","key":"10.1016\/j.jsmc.2021.02.012_bib69","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0165-0173(97)00046-5","article-title":"Functional implications of multiple dopamine receptor subtypes: the D1\/D3 receptor coexistence","volume":"26","author":"Schwartz","year":"1998","journal-title":"Brain Res Rev"},{"issue":"38","key":"10.1016\/j.jsmc.2021.02.012_bib70","doi-asserted-by":"crossref","first-page":"26016","DOI":"10.1074\/jbc.M710349200","article-title":"Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum","volume":"283","author":"Marcellino","year":"2008","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib71","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/mol.114.093096","article-title":"Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer","volume":"86","author":"Guitart","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jsmc.2021.02.012_bib72","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.neuropharm.2012.11.032","article-title":"D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat","volume":"67","author":"Cruz-Trujillo","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib73","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/mol.107.043885","article-title":"Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization","volume":"74","author":"Fiorentini","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"10","key":"10.1016\/j.jsmc.2021.02.012_bib74","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1007\/s12035-019-1564-8","article-title":"Biased G protein-independent signaling of dopamine D1-D3 receptor heteromers in the nucleus accumbens","volume":"56","author":"Guitart","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"3","key":"10.1016\/j.jsmc.2021.02.012_bib75","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nchembio0309-131","article-title":"Building a new conceptual framework for receptor heteromers","volume":"5","author":"Ferr\u00e9","year":"2009","journal-title":"Nat Chem Biol"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib76","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.113.008052","article-title":"G\u00a0protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives","volume":"66","author":"Ferr\u00e9","year":"2014","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.jsmc.2021.02.012_bib77","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tips.2015.01.002","article-title":"The GPCR heterotetramer: challenging classical pharmacology","volume":"36","author":"Ferr\u00e9","year":"2015","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib78","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41467-017-02606-w","article-title":"Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor","volume":"9","author":"Yano","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib79","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/mol.115.101808","article-title":"Evidence for noncanonical neurotransmitter activation: norepinephrine as a dopamine D2-like receptor agonist","volume":"89","author":"S\u00e1nchez-Soto","year":"2016","journal-title":"Mol Pharmacol"},{"issue":"42","key":"10.1016\/j.jsmc.2021.02.012_bib80","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1523\/JNEUROSCI.1894-10.2010","article-title":"Influence of phasic and tonic dopamine release on receptor activation","volume":"30","author":"Dreyer","year":"2010","journal-title":"J\u00a0Neurosci"},{"issue":"5","key":"10.1016\/j.jsmc.2021.02.012_bib81","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.neuron.2010.11.022","article-title":"Dopamine in motivational control: rewarding, aversive, and alerting","volume":"68","author":"Bromberg-Martin","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.jsmc.2021.02.012_bib82","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3389\/fpsyg.2014.01301","article-title":"Striatal direct and indirect pathways control decision-making behavior","volume":"5","author":"Macpherson","year":"2014","journal-title":"Front Psychol"},{"issue":"29","key":"10.1016\/j.jsmc.2021.02.012_bib83","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.2174\/1568026616666160608084834","article-title":"Dopamine targeting drugs for the treatment of schizophrenia: past, present and future","volume":"16","author":"Li","year":"2016","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib84","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.mp.4000249","article-title":"Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients","volume":"2","author":"Steen","year":"1997","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib85","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1096-8628(20000403)96:2<187::AID-AJMG13>3.0.CO;2-8","article-title":"Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen's study on DRD3 and tardive dyskinesia","volume":"96","author":"Eichhammer","year":"2000","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib86","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0893-133X(02)00293-2","article-title":"Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism","volume":"27","author":"Lerer","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"2\u20133","key":"10.1016\/j.jsmc.2021.02.012_bib87","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.schres.2006.01.010","article-title":"Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis","volume":"83","author":"Bakker","year":"2006","journal-title":"Schizophr Res"},{"issue":"3","key":"10.1016\/j.jsmc.2021.02.012_bib88","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1006\/bbrc.1996.1296","article-title":"Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system","volume":"225","author":"Lundstrom","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.jsmc.2021.02.012_bib89","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","article-title":"Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa","volume":"94","author":"Bordet","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.jsmc.2021.02.012_bib90","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.npp.1300456","article-title":"Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior","volume":"29","author":"Neisewander","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"19","key":"10.1016\/j.jsmc.2021.02.012_bib91","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1523\/JNEUROSCI.16-19-06100.1996","article-title":"Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities","volume":"16","author":"Staley","year":"1996","journal-title":"J\u00a0Neurosci"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib92","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1523\/JNEUROSCI.4371-11.2012","article-title":"Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study","volume":"32","author":"Boileau","year":"2012","journal-title":"J\u00a0Neurosci"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib93","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/npp.2013.192","article-title":"Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNO","volume":"39","author":"Payer","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.jsmc.2021.02.012_bib94","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1523\/JNEUROSCI.22-12-05042.2002","article-title":"D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1\/2\/MAP kinase","volume":"22","author":"Gerfen","year":"2002","journal-title":"J\u00a0Neurosci"},{"issue":"5","key":"10.1016\/j.jsmc.2021.02.012_bib95","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1152\/jn.00516.2010","article-title":"Upregulation of D2-class signaling in dopamine-denervated striatum is in part mediated by D3 receptors acting on Ca V 2.1 channels via PIP2 depletion","volume":"105","author":"Prieto","year":"2011","journal-title":"J\u00a0Neurophysiol"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib96","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nbd.2008.11.010","article-title":"Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease","volume":"35","author":"Visanji","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.jsmc.2021.02.012_bib97","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s12035-014-8936-x","article-title":"Stronger dopamine D1 receptor-mediated neurotransmission in dyskinesia","volume":"52","author":"Farr\u00e9","year":"2015","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib98","first-page":"435","article-title":"Dopamine D3 Receptor Modulates l-DOPA-induced dyskinesia by targeting D1 receptor-mediated striatal signaling","volume":"27","author":"Sol\u00eds","year":"2017","journal-title":"Cereb Cortex"},{"issue":"Suppl 1","key":"10.1016\/j.jsmc.2021.02.012_bib99","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.parkreldis.2004.11.005","article-title":"Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors","volume":"11","author":"Guigoni","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.jsmc.2021.02.012_bib100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1212\/WNL.0000000000002285","article-title":"D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia","volume":"86","author":"Payer","year":"2016","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jsmc.2021.02.012_bib101","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/mds.25909","article-title":"Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model","volume":"29","author":"Mahmoudi","year":"2014","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.jsmc.2021.02.012_bib102","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/mds.27630","article-title":"Tardive dyskinesia is associated with altered putamen Akt\/GSK-3\u03b2 signaling in nonhuman primates","volume":"34","author":"Hernandez","year":"2019","journal-title":"Mov Disord"},{"key":"10.1016\/j.jsmc.2021.02.012_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sleep.2016.01.017","article-title":"Guidelines for the first-line treatment of restless legs syndrome\/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation","volume":"21","author":"Garcia-Borreguero","year":"2016","journal-title":"Sleep Med"},{"issue":"8","key":"10.1016\/j.jsmc.2021.02.012_bib104","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.sleep.2014.05.009","article-title":"Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis-Ekbom disease)","volume":"15","author":"Earley","year":"2014","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajh.23397","article-title":"The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia","volume":"88","author":"Allen","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jsmc.2021.02.012_bib106","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fneur.2020.00298","article-title":"Correlates of nonanemic iron deficiency in restless legs syndrome","volume":"11","author":"Zhu","year":"2020","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib107","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jns.2006.04.008","article-title":"Is ferroportin-hepcidin signaling altered in restless legs syndrome?","volume":"247","author":"Clardy","year":"2006","journal-title":"J\u00a0Neurol Sci"},{"issue":"6","key":"10.1016\/j.jsmc.2021.02.012_bib108","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/sleep\/31.6.847","article-title":"Altered iron metabolism in lymphocytes from subjects with restless legs syndrome","volume":"31","author":"Earley","year":"2008","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.jsmc.2021.02.012_bib109","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/01.WNL.0000078887.16593.12","article-title":"Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome","volume":"61","author":"Connor","year":"2003","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jsmc.2021.02.012_bib110","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/brain\/awp125","article-title":"Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome","volume":"132","author":"Connor","year":"2009","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.jsmc.2021.02.012_bib111","doi-asserted-by":"crossref","first-page":"zsz079","DOI":"10.1093\/sleep\/zsz079","article-title":"Extracellular vesicles reveal abnormalities in neuronal iron metabolism in restless legs syndrome","volume":"42","author":"Chawla","year":"2019","journal-title":"Sleep"},{"key":"10.1016\/j.jsmc.2021.02.012_bib112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.sleep.2016.07.028","article-title":"Iron and restless legs syndrome: treatment, genetics and pathophysiology","volume":"31","author":"Connor","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.jsmc.2021.02.012_bib113","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/bs.apha.2019.02.005","article-title":"Iron uptake at the blood-brain barrier is influenced by sex and genotype","volume":"84","author":"Wade","year":"2019","journal-title":"Adv Pharmacol"},{"issue":"10","key":"10.1016\/j.jsmc.2021.02.012_bib114","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.biochi.2009.04.009","article-title":"Systems genetics analysis of iron regulation in the brain","volume":"91","author":"Jellen","year":"2009","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10048-012-0321-1","article-title":"Systems genetic analysis of the effects of iron deficiency in mouse brain","volume":"13","author":"Jellen","year":"2012","journal-title":"Neurogenetics"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib116","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ana.22435","article-title":"Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis","volume":"70","author":"Catoire","year":"2011","journal-title":"Ann Neurol"},{"issue":"18","key":"10.1016\/j.jsmc.2021.02.012_bib117","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1093\/hmg\/dds221","article-title":"Motor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice","volume":"21","author":"DeAndrade","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jsmc.2021.02.012_bib118","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.sleep.2017.11.1126","article-title":"International Restless Legs Syndrome Study Group (IRLSSG). Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome\/Willis-Ekbom disease in adults and children: an IRLSSG task force report","volume":"41","author":"Allen","year":"2018","journal-title":"Sleep Med"},{"issue":"39","key":"10.1016\/j.jsmc.2021.02.012_bib119","doi-asserted-by":"crossref","first-page":"13437","DOI":"10.1021\/bi981462g","article-title":"Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2.3 A resolution: self-hydroxylation of Phe300 and the pterin-binding site","volume":"37","author":"Goodwill","year":"1998","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.sleep.2007.11.012","article-title":"Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis","volume":"10","author":"Allen","year":"2009","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib121","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5665\/sleep.2300","article-title":"Increased synaptic dopamine in the putamen in restless legs syndrome","volume":"36","author":"Earley","year":"2013","journal-title":"Sleep"},{"issue":"1\u20132","key":"10.1016\/j.jsmc.2021.02.012_bib122","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(81)90510-2","article-title":"Topographical and cytological localization of iron in rat and monkey brains","volume":"215","author":"Francois","year":"1981","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.jsmc.2021.02.012_bib123","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0306-4522(84)90046-0","article-title":"The regional distribution and cellular localization of iron in the rat brain","volume":"11","author":"Hill","year":"1984","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.jsmc.2021.02.012_bib124","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/mds.22070","article-title":"Multiregional brain iron deficiency in restless legs syndrome","volume":"23","author":"Godau","year":"2008","journal-title":"Mov Disord"},{"issue":"13","key":"10.1016\/j.jsmc.2021.02.012_bib125","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/mds.25576","article-title":"Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging","volume":"28","author":"Rizzo","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.jsmc.2021.02.012_bib126","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuropharm.2016.09.002","article-title":"Adenosine receptors as markers of brain iron deficiency: implications for Restless Legs Syndrome","volume":"111","author":"Quiroz","year":"2016","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.jsmc.2021.02.012_bib127","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/mds.27133","article-title":"Motor hyperactivity of the iron-deficient rat - an animal model of restless legs syndrome","volume":"32","author":"Lai","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.jsmc.2021.02.012_bib128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.sleep.2020.01.024","article-title":"Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome","volume":"71","author":"Allen","year":"2020","journal-title":"Sleep Med"},{"key":"10.1016\/j.jsmc.2021.02.012_bib129","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.expneurol.2014.06.023","article-title":"Low brain iron effects and reversibility on striatal dopamine dynamics","volume":"261","author":"Unger","year":"2014","journal-title":"Exp Neurol"},{"issue":"12","key":"10.1016\/j.jsmc.2021.02.012_bib130","first-page":"2282","article-title":"In\u00a0vivo dopamine metabolism is altered in iron-deficient anemic rats","volume":"127","author":"Nelson","year":"1997","journal-title":"J\u00a0Nutr"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib131","first-page":"1174","article-title":"Neonatal iron deficiency results in irreversible changes in dopamine function in rats","volume":"133","author":"Beard","year":"2003","journal-title":"J\u00a0Nutr"},{"issue":"22","key":"10.1016\/j.jsmc.2021.02.012_bib132","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1212\/WNL.0b013e318294b3f6","article-title":"Thalamic glutamate\/glutamine in restless legs syndrome: increased and related to disturbed sleep","volume":"80","author":"Allen","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib133","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tips.2006.12.006","article-title":"Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission","volume":"28","author":"Dooley","year":"2007","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib134","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","article-title":"Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum","volume":"29","author":"Matsuda","year":"2009","journal-title":"J\u00a0Neurosci"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib135","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.cell.2018.01.008","article-title":"Dopamine secretion is mediated by sparse active zone-like release sites","volume":"172","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib136","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuron.2012.04.038","article-title":"Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons","volume":"75","author":"Threlfell","year":"2012","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.jsmc.2021.02.012_bib137","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1093\/cercor\/bhw252","article-title":"Cortical control of striatal dopamine transmission via striatal cholinergic interneurons","volume":"26","author":"Kosillo","year":"2016","journal-title":"Cereb Cortex"},{"issue":"39","key":"10.1016\/j.jsmc.2021.02.012_bib138","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.1523\/JNEUROSCI.1327-20.2020","article-title":"Prefrontal cortex-driven dopamine signals in the striatum show unique spatial and pharmacological properties","volume":"40","author":"Adrover","year":"2020","journal-title":"J\u00a0Neurosci"},{"issue":"6","key":"10.1016\/j.jsmc.2021.02.012_bib139","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ana.25104","article-title":"Targeting hypersensitive corticostriatal terminals in restless legs syndrome","volume":"82","author":"Yepes","year":"2017","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.jsmc.2021.02.012_bib140","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/mp.2011.93","article-title":"Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain","volume":"17","author":"Gonz\u00e1lez","year":"2012","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib141","doi-asserted-by":"crossref","first-page":"e1601631","DOI":"10.1126\/sciadv.1601631","article-title":"Key role of the dopamine D4 receptor in the modulation of corticostriatal glutamatergic neurotransmission","volume":"3","author":"Bonaventura","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/j.jsmc.2021.02.012_bib142","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.sleep.2017.06.033","article-title":"Combined resting state functional magnetic resonance imaging and diffusion tensor imaging study in patients with idiopathic restless legs syndrome","volume":"38","author":"Zhuo","year":"2017","journal-title":"Sleep Med"},{"issue":"21","key":"10.1016\/j.jsmc.2021.02.012_bib143","doi-asserted-by":"crossref","first-page":"e1834","DOI":"10.1212\/WNL.0000000000005562","article-title":"Involvement of the central somatosensory system in restless legs syndrome: a neuroimaging study","volume":"90","author":"Lee","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jsmc.2021.02.012_bib144","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cne.1337","article-title":"Organization of corticostriatal projections from the vibrissal representations in the primary motor and somatosensory cortical areas of rodents","volume":"439","author":"Hoffer","year":"2001","journal-title":"J\u00a0Comp Neurol"},{"issue":"6","key":"10.1016\/j.jsmc.2021.02.012_bib145","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nn.3397","article-title":"Convergent cortical innervation of striatal projection neurons","volume":"16","author":"Kress","year":"2013","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.jsmc.2021.02.012_bib146","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jsmc.2011.04.006","article-title":"Genetics of restless legs syndrome: mendelian, complex, and everything in between","volume":"6","author":"Schormair","year":"2011","journal-title":"Sleep Med Clin"},{"issue":"11","key":"10.1016\/j.jsmc.2021.02.012_bib147","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1474-4422(17)30327-7","article-title":"Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis","volume":"16","author":"Schormair","year":"2017","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.jsmc.2021.02.012_bib148","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1101\/gr.166751.113","article-title":"Restless legs syndrome-associated intronic common variant in Meis1 alters enhancer function in the developing telencephalon","volume":"24","author":"Spieler","year":"2014","journal-title":"Genome Res"},{"issue":"5","key":"10.1016\/j.jsmc.2021.02.012_bib149","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0277-19.2019","article-title":"The role of BTBD9 in striatum and restless legs syndrome","volume":"6","author":"Lyu","year":"2019","journal-title":"eNeuro"},{"key":"10.1016\/j.jsmc.2021.02.012_bib150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.neuro.24.1.31","article-title":"The role and regulation of adenosine in the central nervous system","volume":"24","author":"Dunwiddie","year":"2001","journal-title":"Annu Rev Neurosci"},{"issue":"7","key":"10.1016\/j.jsmc.2021.02.012_bib151","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","article-title":"Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers","volume":"26","author":"Ciruela","year":"2006","journal-title":"J\u00a0Neurosci"},{"issue":"Suppl 1","key":"10.1016\/j.jsmc.2021.02.012_bib152","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.3233\/JAD-2010-1400","article-title":"Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine","volume":"20","author":"Ferr\u00e9","year":"2010","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"6508","key":"10.1016\/j.jsmc.2021.02.012_bib153","doi-asserted-by":"crossref","first-page":"eabb0556","DOI":"10.1126\/science.abb0556","article-title":"Regulation of sleep homeostasis mediator adenosine by basal forebrain glutamatergic neurons","volume":"369","author":"Peng","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jsmc.2021.02.012_bib154","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.apha.2018.12.005","article-title":"Adenosine mechanisms and hypersensitive corticostriatal terminals in restless legs syndrome. Rationale for the use of inhibitors of adenosine transport","volume":"84","author":"Ferr\u00e9","year":"2019","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.jsmc.2021.02.012_bib155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.sleep.2018.02.002","article-title":"Treatment of restless legs syndrome\/Willis-Ekbom disease with the non-selective ENT1\/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis","volume":"45","author":"Garcia-Borreguero","year":"2018","journal-title":"Sleep Med"}],"container-title":["Sleep Medicine Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556407X2100014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556407X2100014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:00:23Z","timestamp":1761562823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556407X2100014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":155,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1556407X2100014X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsmc.2021.02.012","relation":{},"ISSN":["1556-407X"],"issn-type":[{"value":"1556-407X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Akathisia and Restless Legs Syndrome","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsmc.2021.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}